Merck (WBO:MRK) Debt-to-Asset : 0.33 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Merck Debt-to-Asset?

Merck's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €1,258 Mil. Merck's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €30,887 Mil. Merck's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was €97,821 Mil. Merck's debt to asset for the quarter that ended in Dec. 2023 was 0.33.

Merck Debt-to-Asset Historical Data

The historical data trend for Merck's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Debt-to-Asset Chart

Merck Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.31

0.35

0.31

0.28

0.33

Merck Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial															0.29	0.35	0.33	0.33	-

Competitive Comparison of Merck's Debt-to-Asset

For the Drug Manufacturers - General subindustry, Merck's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merck's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Merck's Debt-to-Asset falls into.

Merck Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Merck's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1258.124	+	30887.311)	/	97820.975
	=	0.33

Merck's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1258.124	+	30887.311)	/	97820.975
	=	0.33

Merck (WBO:MRK) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Merck Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Merck's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck (WBO:MRK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (WBO:MRK) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany MRK:Chile MRCK34:Brazil MRK:Argentina

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.